Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05444543 · ClinicalTrials.gov registry record · Phase 4
Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT05444543 is a Phase 4 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT05444543, a Phase 4 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of our research study is to assess whether patients with EoE who have achieved control of their disease on topical Fluticasone or Budesonide are able to cycle or take breaks from their treatment with continued remission of their EoE. There will be 30 participants enrolled in this study. There will be 15 patients who will stay on steroid therapy every day and 15 patients who will cycle their steroid therapy on and off to help us compare the two groups. The cycling group will cycle their steroid therapy in a three-months on three-months off fashion.
Interventions
- DRUG Budesonide
- DRUG Fluticasone Propionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2023-10-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05444543
The ClinicalTrials.gov registry entry for NCT05444543 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Budesonide is the first listed.
NCT05444543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05444543 about?
NCT05444543 is a clinical study titled "Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)". The purpose of our research study is to assess whether patients with EoE who have achieved control of their disease on topical Fluticasone or Budesonide are able to cycle or take breaks from their treatment with continued remission of their EoE. There will be 30 participants enrolled in this study. ...
What is the current status of trial NCT05444543?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2021-11-17. Estimated completion is 2023-10-13.
What interventions are being tested in trial NCT05444543?
The interventions under investigation include: Budesonide (DRUG), Fluticasone Propionate (DRUG).
Who is sponsoring clinical trial NCT05444543?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.